← Back to guidelines
Cardiology10 papers

Enteroviral encephalomyelitis

Last edited: 4/22/2026

Overview

Enteroviral encephalomyelitis encompasses severe neurological manifestations caused by enteroviruses, including meningitis, encephalitis, and myocarditis, often presenting acutely but potentially persisting or recurring 13.

Diagnosis

  • Clinical Presentation: Meningitis, encephalitis, myocarditis, pleurodynia, and systemic febrile illness 34.
  • Laboratory Tests:
  • - Culture-Negative Cases: Utilize seminested PCR for detecting enterovirus RNA, even in culture-negative samples 1. - Serology: Monitor antibody titers for evidence of recent infection, especially in paired sera showing significant increases 4.
  • Imaging and Other Tests: Not specifically detailed in abstracts provided.
  • Management

  • Supportive Care: Focus on symptom management including neurological support, cardiac monitoring, and fluid/electrolyte balance 13.
  • Antiviral Therapy: No specific antiviral treatments mentioned in the abstracts; management remains largely supportive 13.
  • Monitoring: Regular clinical and laboratory monitoring to assess disease progression and response to supportive care 13.
  • Special Populations

  • Pediatrics: Enteroviral infections in early infancy can be severe, often manifesting as meningitis or systemic disease, with Coxsackie B and echoviruses being predominant 3.
  • Immunocompromised: Susceptibility to chronic and persistent infections noted, highlighting the importance of sensitive diagnostic tools like PCR 1.
  • Pregnancy: Potential vertical transmission leading to severe neonatal outcomes, such as myocarditis, is documented 4.
  • Key Recommendations

  • Utilize seminested PCR for diagnosing enteroviral infections, especially in culture-negative cases to confirm persistent or chronic infections (Evidence: Strong 1).
  • Monitor antibody titers in paired sera to detect recent enteroviral infections, particularly useful in confirming disease causality [Evidence: Moderate 4].
  • Employ supportive care measures tailored to the clinical presentation, including neurological and cardiac support, given the severity of enteroviral encephalomyelitis (Evidence: Expert opinion).
  • References

    1 Leparc I, Aymard M, Fuchs F. Acute, chronic and persistent enterovirus and poliovirus infections: detection of viral genome by seminested PCR amplification in culture-negative samples. Molecular and cellular probes 1994. link 2 Beck MA, Tracy SM. Evidence for a group-specific enteroviral antigen(s) recognized by human T cells. Journal of clinical microbiology 1990. link 3 Morens DM. Enteroviral disease in early infancy. The Journal of pediatrics 1978. link80422-3) 4 McLean DM, Coleman MA, Larke RP, McNaughton GA. Viral infections of Toronto children during 1965. I. Enteroviral disease. Canadian Medical Association journal 1966. link

    Original source

    1. [1]
    2. [2]
      Evidence for a group-specific enteroviral antigen(s) recognized by human T cells.Beck MA, Tracy SM Journal of clinical microbiology (1990)
    3. [3]
      Enteroviral disease in early infancy.Morens DM The Journal of pediatrics (1978)
    4. [4]
      Viral infections of Toronto children during 1965. I. Enteroviral disease.McLean DM, Coleman MA, Larke RP, McNaughton GA Canadian Medical Association journal (1966)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG